Paola Corazao
About Paola Corazao
Paola Corazao is a Responsable Regional Medico Scientifique (MSL) in Immuno-Oncologie at Bristol Myers Squibb, with a strong background in oncology and immunotherapy.
Current Role at Bristol Myers Squibb
Paola Corazao currently holds the position of Responsable Regional Medico Scientifique (MSL) Immuno-Oncologie at Bristol Myers Squibb. She commenced her tenure in May 2021. Within this role, she is responsible for providing scientific and medical support across the regional level, focusing on immuno-oncology. This involves liaising with healthcare professionals, contributing to scientific discussions, and supporting medical strategies related to the company’s immunotherapy products and protocols.
Experience at Pierre Fabre Group
From 2019 to 2021, Paola Corazao served as Responsable Médical Regional - Oncologie at Pierre Fabre Group. During her two-year tenure, she was tasked with overseeing regional medical operations in the field of oncology. Her role encompassed engaging with regional healthcare providers, supporting clinical studies, and fostering the dissemination of scientific and medical knowledge related to oncology treatments and practices.
Clinical Research at CHRU Lille
Paola Corazao worked at CHRU Lille as an Ingénieur de Recherche clinique from 2014 to 2019. Over these five years in the Région de Lille, France, she was engaged in clinical research activities. Her responsibilities included conducting clinical trials, managing study protocols, and collaborating with other researchers to advance medical and clinical knowledge.
Doctoral Research at INSERM U837 équipe 4
Between 2011 and 2014, Paola Corazao pursued her doctoral research at INSERM U837 équipe 4. Her research focused on oncology and involved in-depth studies in cellular biology and cancer sciences. This work contributed to the body of knowledge in her field and involved detailed experimental and theoretical research practices.
Educational Background in Oncology and Immunotherapy
Paola Corazao has a robust academic background in oncology and immunotherapy. She achieved a Doctor of Philosophy - PhD in Oncologie et biologie du cancer from Université du Droit et de la Santé (Lille II) between 2011 and 2014. Additionally, she obtained a Diplôme Universitaire in Immuno-oncologie et Immunotherapies from the same university in 2018. Her academic pursuits also include a DU in Immunologie Antitumorale from Université de Lille in 2018 and a Master 2 in Biologie-Santé specialité biologie cellulaire from Université du Droit et de la Santé (Lille II) in 2011. She also holds a Bachelor's degree in Biotechnology from Universidad Católica de Santa María, completed in 2008.